Benzinga | Aug 19, 2020 09:55AM EDT

Sidoti & Co. Upgrades PetMed Express to Buy, Raises Price Target to $41

Sidoti & Co. analyst Anthony Lebiedzinski upgrades PetMed Express (NASDAQ:PETS) from Neutral to Buy and raises the price target from $37 to $41.